Tag archive for ‘DazaSite’
InSite Vision: Initiating Coverage on a Promising Company with a Robust Late Stage Product Portfolio
I have just published a new report and initiated coverage of InSite Vision (INSV, $0.30) with a Buy. The core technology of InSite Vision is its DuraSite drug delivery system that delivers drugs more effectively to the eye. The continual blinking of the eye can quickly wash out topical formulations and in order to retain […]